Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sasmita Mishra

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Pharmacology Research & Perspectives|October 31, 2015
Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclaxScott Ackler, Anatol Oleksijew, Jun Chen, et al.
Pharmacology|July 26, 2017
A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor ReceptorKedar S Vaidya, Anatol Oleksijew, Lora A Tucker, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Hepatitis E, Schistosomiasis and Echinococcosis-Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth RestrictionJanine Zöllkau, Juliane Ankert, Mathias W Pletz, et al.
Human Genetics|September 1, 2019
GPT2 mutations in autosomal recessive developmental disability: extending the clinical phenotype and population prevalence estimatesQing Ouyang, Brian C Kavanaugh, Lena Joesch-Cohen, et al.
Cancer Research|May 17, 2018
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug ConjugatesJames W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive featuresQing Ouyang, Tojo Nakayama, Ozan Baytas, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Pharmacology Research & Perspectives|October 31, 2015
Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclaxScott Ackler, Anatol Oleksijew, Jun Chen, et al.
Pharmacology|July 26, 2017
A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor ReceptorKedar S Vaidya, Anatol Oleksijew, Lora A Tucker, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Hepatitis E, Schistosomiasis and Echinococcosis-Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth RestrictionJanine Zöllkau, Juliane Ankert, Mathias W Pletz, et al.
Human Genetics|September 1, 2019
GPT2 mutations in autosomal recessive developmental disability: extending the clinical phenotype and population prevalence estimatesQing Ouyang, Brian C Kavanaugh, Lena Joesch-Cohen, et al.
Cancer Research|May 17, 2018
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug ConjugatesJames W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive featuresQing Ouyang, Tojo Nakayama, Ozan Baytas, et al.
Pageof 6